GlassScriptPhysician profile
Sarah Arshad
NPI 1255744157
$280.62
in general payments reported to CMS, 2019-2025
7 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $122 · 2020: $30.41 · 2021: $19.52 · 2022: $109.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $121.88 | 2019 | |
| Janssen Pharmaceuticals, INC | $43.67 | 2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $34.44 | 2020-2022 | |
| Merck Sharp & Dohme LLC | $24.53 | 2022 | |
| Novartis Pharmaceuticals Corporation | $22.18 | 2022 | |
| Philips North America LLC | $19.52 | 2021 | |
| Amarin Pharma, INC. | $14.40 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sarah Arshad listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.